0001209191-23-023943.txt : 20230410 0001209191-23-023943.hdr.sgml : 20230410 20230410200220 ACCESSION NUMBER: 0001209191-23-023943 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230331 FILED AS OF DATE: 20230410 DATE AS OF CHANGE: 20230410 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GRAY MARY ANN CENTRAL INDEX KEY: 0001261974 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38997 FILM NUMBER: 23812150 MAIL ADDRESS: STREET 1: 201 W 70TH ST, SUITE 23K CITY: NEW YORK STATE: NY ZIP: 10023 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: RAPT Therapeutics, Inc. CENTRAL INDEX KEY: 0001673772 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473313701 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: (650) 489-9000 MAIL ADDRESS: STREET 1: 561 ECCLES AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 FORMER COMPANY: FORMER CONFORMED NAME: FLX Bio, Inc. DATE OF NAME CHANGE: 20160504 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-03-31 0 0001673772 RAPT Therapeutics, Inc. RAPT 0001261974 GRAY MARY ANN C/O RAPT THERAPEUTICS, INC. 561 ECCLES AVENUE SOUTH SAN FRANCISCO CA 94080 1 0 0 0 0 Stock Option (right to buy) 18.35 2023-03-31 4 A 0 4477 14.52 A 2033-03-30 Common Stock 4477 4477 D The shares subject to the option vest in four equal quarterly installments on the last day of each fiscal quarter in 2023 with the first installment vesting on March 31, 2023, provided that the reporting person is in service as a director on each such vesting date. This option was issued to the reporting person pursuant to the Issuer's Amended and Restated Non-Employee Director Compensation Policy in lieu of an annual cash retainers for service on the Board of Directors and committees thereof in the aggregate amount of $65,000. /s/ Rodney Young, Attorney-in-Fact for Mary Ann Gray 2019-04-10